Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ultralife** is an over-the-counter ophthalmic lubricant developed and manufactured by **Grevis Pharma** (Grevis Pharmaceuticals). It is formulated as eye drops containing a combination of **polyethylene glycol** (0.4%) and **propylene glycol** (0.3%). The product is primarily indicated for the temporary relief of burning, irritation, and discomfort associated with dry eye syndrome, environmental factors (such as wind, smoke, or air conditioning), and digital eye strain. Mechanistically, the active ingredients function as humectants and lubricants that mimic natural tears, coating the ocular surface to reduce moisture evaporation and facilitate smooth movement of the eyelids over the cornea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ultralife.